Klenerman L, McCabe C, Cogley D, Crerand S, Laing P, White M
Department of Orthopaedic and Accident Surgery Royal Liverpool Hospital, UK.
Diabet Med. 1996 Jun;13(6):561-3. doi: 10.1002/(SICI)1096-9136(199606)13:6<561::AID-DIA112>3.0.CO;2-P.
An examination of the reproducibility of three tests for identifying patients at risk of diabetic foot complications is reported. One thousand and one patients attending a general diabetic outpatient clinic at the Royal Liverpool University Hospital underwent screening using the Semmes-Weinstein monofilaments, the biothesiometer, and palpation of pedal pulses. Two hundred and fifty-nine patients who were found to have a deficit on at least one of these tests were given a second appointment where the tests were repeated. Two hundred and twenty-nine patients attended for their second appointment. The expected range of variation in readings for the biothesiometer was 5 log hertz, sufficient variation to make the biothesiometer unacceptable as a screening instrument. The range of reproducibility for the four pedal pulses was from 68% to 81%, also an unacceptable level of variation. Over 85% of the results for the Semmes-Weinstein monofilaments were the same on the first and second measurement. Of the three instruments examined in this study, only the Semmes-Weinstein monofilaments have sufficient reproducibility in the clinical setting for them to be recommended for general use as a screening test for risk of diabetic foot complications.
本文报告了三项用于识别糖尿病足并发症风险患者的检查的可重复性。1001名在皇家利物浦大学医院普通糖尿病门诊就诊的患者接受了Semmes-Weinstein单丝检查、生物感觉阈值测量仪检查和足部脉搏触诊筛查。259名在这些检查中至少一项存在缺陷的患者被安排了第二次检查,重复进行这些检查。229名患者前来进行第二次检查。生物感觉阈值测量仪读数的预期变化范围为5对数赫兹,这种变化程度足以使生物感觉阈值测量仪不能作为筛查工具。四个足部脉搏的可重复性范围为68%至81%,这也是不可接受的变化水平。Semmes-Weinstein单丝检查超过85%的结果在第一次和第二次测量时相同。在本研究中检查的三种仪器中,只有Semmes-Weinstein单丝检查在临床环境中具有足够的可重复性,因此推荐将其作为糖尿病足并发症风险的常规筛查测试。